إعلان
إعلان
TCRX
TScan Therapeutics, Inc. Common Stock
1.21
USDبرعاية
+0.04
+2.97%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
قبل الإفتتاح
1.22
+0.01
+0.83%
تقارير أرباح TCRX
النسبة الإيجابية المفاجئة
TCRX تفوق 12 من 18 آخر التقديرات.
67%
التقرير التالي
بيانات التقرير القادم
٠٤ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$2.09M
/-$0.24
التغير الضمني من Q3 25 (Revenue/ EPS)
-16.81%
/-14.29%
التغير الضمني من Q4 24 (Revenue/ EPS)
+214.13%
/-20.00%
TScan Therapeutics, Inc. Common Stock earnings per share and revenue
On ١٢ نوفمبر ٢٠٢٥, TCRX reported earnings of -0.28 USD per share (EPS) for Q3 25, beating the estimate of -0.30 USD, resulting in a 7.04% surprise. Revenue reached 2.51 مليون, compared to an expected 2.02 مليون, with a 24.33% difference. The market reacted with a -2.46% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 المحللين forecast an EPS of -0.24 USD, with revenue projected to reach 2.09 مليون USD, implying an نقصان of -14.29% EPS, and نقصان of -16.81% in Revenue from the last quarter.
الأسئلة الشائعة
What were TScan Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, TScan Therapeutics, Inc. Common Stock reported EPS of -$0.28, beating estimates by 7.04%, and revenue of $2.51M, 24.33% above expectations.
How did the market react to TScan Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -2.46%, changed from $1.22 before the earnings release to $1.19 the day after.
When is TScan Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٠٤ مارس ٢٠٢٦.
What are the forecasts for TScan Therapeutics, Inc. Common Stock's next earnings report?
Based on 9
المحللين, TScan Therapeutics, Inc. Common Stock is expected to report EPS of -$0.24 and revenue of $2.09M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان